董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Kevin O'Byrne Chair of the Board, Director 61 50.70万美元 2.72 2026-04-29
J. Erik Fyrwald Chief Executive Officer and Director 66 1500.29万美元 12.33 2026-04-29
Jesus B. Mantas Independent Director 57 23.77万美元 0.23 2026-04-29
Dawn C. Willoughby Independent Director 57 33.00万美元 0.66 2026-04-29
Cynthia T. Jamison Independent Director 66 未披露 未持股 2026-04-29
Brett Icahn Independent Director 46 15.94万美元 0.17 2026-04-29
Jesus B. Mantas Independent Director 57 未披露 未持股 2026-04-29
Richard Mulligan Independent Director 72 15.94万美元 0.17 2026-04-29
Mehmood Khan Independent Director 67 31.50万美元 0.32 2026-04-29
Paul J. Fribourg Independent Director 72 22.77万美元 229.89 2026-04-29
Virginia C. Drosos Independent Director 63 26.30万美元 0.24 2026-04-29
Cynthia T. Jamison Independent Director 66 33.50万美元 0.32 2026-04-29

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
J. Erik Fyrwald Chief Executive Officer and Director 66 1500.29万美元 12.33 2026-04-29
Deborah Borg Chief People and Culture Officer and Executive Vice President 49 730.89万美元 未持股 2026-04-29
Leticia Goncalves President, Health & Biosciences 51 580.91万美元 0.73 2026-04-29
Michael DeVeau Chief Financial Officer and Executive Vice President 45 370.85万美元 1.90 2026-04-29
Ana Paula Mendonca President, Scent 57 未披露 未持股 2026-04-29
Ralf Finzel Executive Vice President and Global Operations Officer 62 282.37万美元 未持股 2026-04-29
Yuvraj Arora President, Taste and Chief Commercial Officer 54 473.57万美元 未持股 2026-04-29
Stephen Landsman Executive Vice President and General Counsel 66 未披露 未持股 2026-04-29
Andres Muller President, Food Ingredients 61 361.33万美元 0.38 2026-04-29
Marc Birenkrant Controller and Chief Accounting Officer -- 未披露 未持股 2026-04-29
Vivek Verma Chief Information Officer and Executive Vice President 57 未披露 未持股 2026-04-29

董事简历

中英对照 |  中文 |  英文
Kevin O'Byrne

Kevin O'Byrne,于2017年至2023年3月期间担任英国第二大零售商J Sainsbury plc的首席财务官兼董事。他曾担任Poundland Group Limited首席执行官至2016年12月,并于2008年至2015年在Kingfisher plc担任执行职务,包括部门首席执行官/英国、中国和土耳其主席、百安居英国和爱尔兰首席执行官以及集团财务总监。在此之前,O'Byrne先生是Dixons Retail PLC的集团财务总监和Quaker Oats的欧洲财务总监。奥伯恩拥有都柏林三一学院商业研究文学学士学位,自1990年以来,他一直是英格兰和威尔士特许会计师协会的会员。


Kevin O'Byrne served, until March 2023, as Chief Financial Officer and Director of J Sainsbury plc, the second largest retailer in the United Kingdom. He was previoly Chief Executive Officer of Poundland Group Plc and held executive roles at Kingfisher Plc, including Divisional CEO UK, China and Turkey, Chief Executive Officer of B&Q UK & Ireland and Group Finance Director. Prior to this, he was Group Finance Director of Dixons Retail plc and European Finance Director of Quaker Oats. Mr. O'Byrne joined the IFF Board in March 2023 and was elected Chair of the Board in May 2025. Mr. O'Byrne is also Chair of the Board of Centrica plc, a FTSE 100 listed energy and services company, where he previoly was Senior Independent Director and Chair of the Audit and Risk Committee. He has over 35 years of experience on public company boards in the UK, Germany and , as an executive and non executive. He was previoly Senior Independent Director and Chair of the Audit Committee of Land Securities Group plc.Mr. O'Byrne holds a Bachelor of Arts degree in Biness Studies from Trinity College, Dublin and he has been a Fellow of the Institute of Chartered Accountants in England & Wales since 1990.
Kevin O'Byrne,于2017年至2023年3月期间担任英国第二大零售商J Sainsbury plc的首席财务官兼董事。他曾担任Poundland Group Limited首席执行官至2016年12月,并于2008年至2015年在Kingfisher plc担任执行职务,包括部门首席执行官/英国、中国和土耳其主席、百安居英国和爱尔兰首席执行官以及集团财务总监。在此之前,O'Byrne先生是Dixons Retail PLC的集团财务总监和Quaker Oats的欧洲财务总监。奥伯恩拥有都柏林三一学院商业研究文学学士学位,自1990年以来,他一直是英格兰和威尔士特许会计师协会的会员。
Kevin O'Byrne served, until March 2023, as Chief Financial Officer and Director of J Sainsbury plc, the second largest retailer in the United Kingdom. He was previoly Chief Executive Officer of Poundland Group Plc and held executive roles at Kingfisher Plc, including Divisional CEO UK, China and Turkey, Chief Executive Officer of B&Q UK & Ireland and Group Finance Director. Prior to this, he was Group Finance Director of Dixons Retail plc and European Finance Director of Quaker Oats. Mr. O'Byrne joined the IFF Board in March 2023 and was elected Chair of the Board in May 2025. Mr. O'Byrne is also Chair of the Board of Centrica plc, a FTSE 100 listed energy and services company, where he previoly was Senior Independent Director and Chair of the Audit and Risk Committee. He has over 35 years of experience on public company boards in the UK, Germany and , as an executive and non executive. He was previoly Senior Independent Director and Chair of the Audit Committee of Land Securities Group plc.Mr. O'Byrne holds a Bachelor of Arts degree in Biness Studies from Trinity College, Dublin and he has been a Fellow of the Institute of Chartered Accountants in England & Wales since 1990.
J. Erik Fyrwald

J. Erik Fyrwald,自2024年2月6日起担任首席执行官、董事会成员。他从先正达加入International Flavors & Fragrances Inc.,自2016年起担任首席执行官。在任职先正达之前,Fyrwald先生于2012年5月至2016年5月期间担任Univar Solutions的首席执行官,于2008年至2011年期间担任纳尔科的董事长兼首席执行官,在纳尔科与艺康集团公司合并后,他担任艺康的总裁。Fyrwald先生的职业生涯始于1981年的杜邦公司。Fyrwald先生在杜邦27年期间担任过多个职位,包括E.I. du Pont de Nemours and Company农业和营养部门的集团副总裁以及杜邦营养和健康业务的副总裁兼总经理。Fyrwald先生就读于特拉华大学,并于1981年获得化学工程理学学士学位。他还于1998年在哈佛商学院完成了高级管理课程。


J. Erik Fyrwald served as Chief Executive Officer and a member of Board of Directors since February 6, 2024. He joined from Syngenta Group, where he served as Chief Executive Officer since 2016. Prior to his role at Syngenta, Mr. Fyrwald served as Chief Executive Officer of Univar Solutions from May 2012 until May 2016, Chairman and Chief Executive Officer of Nalco Company from 2008 until 2011, when Nalco merged with Ecolab Inc. Following the merger, he served as President of Ecolab. Mr. Fyrwald began his career at DuPont in 1981. During his 27 years at DuPont, Mr. Fyrwald held a number of positions, including Group Vice President of the Agriculture and Nutrition Division at E.I. du Pont de Nems and Company and Vice President and General Manager of DuPont's Nutrition and Health Biness. He serves as a director of Eli Lilly and Company, a pharmaceutical company that develops, manufactures, and sells prescription drugs and other healthcare products, since 2005.Mr. Fyrwald attended the University of Delaware, where he received a Bachelor of Science in Chemical Engineering in 1981. He also completed the Advanced Management Program at Harvard Biness School in 1998.
J. Erik Fyrwald,自2024年2月6日起担任首席执行官、董事会成员。他从先正达加入International Flavors & Fragrances Inc.,自2016年起担任首席执行官。在任职先正达之前,Fyrwald先生于2012年5月至2016年5月期间担任Univar Solutions的首席执行官,于2008年至2011年期间担任纳尔科的董事长兼首席执行官,在纳尔科与艺康集团公司合并后,他担任艺康的总裁。Fyrwald先生的职业生涯始于1981年的杜邦公司。Fyrwald先生在杜邦27年期间担任过多个职位,包括E.I. du Pont de Nemours and Company农业和营养部门的集团副总裁以及杜邦营养和健康业务的副总裁兼总经理。Fyrwald先生就读于特拉华大学,并于1981年获得化学工程理学学士学位。他还于1998年在哈佛商学院完成了高级管理课程。
J. Erik Fyrwald served as Chief Executive Officer and a member of Board of Directors since February 6, 2024. He joined from Syngenta Group, where he served as Chief Executive Officer since 2016. Prior to his role at Syngenta, Mr. Fyrwald served as Chief Executive Officer of Univar Solutions from May 2012 until May 2016, Chairman and Chief Executive Officer of Nalco Company from 2008 until 2011, when Nalco merged with Ecolab Inc. Following the merger, he served as President of Ecolab. Mr. Fyrwald began his career at DuPont in 1981. During his 27 years at DuPont, Mr. Fyrwald held a number of positions, including Group Vice President of the Agriculture and Nutrition Division at E.I. du Pont de Nems and Company and Vice President and General Manager of DuPont's Nutrition and Health Biness. He serves as a director of Eli Lilly and Company, a pharmaceutical company that develops, manufactures, and sells prescription drugs and other healthcare products, since 2005.Mr. Fyrwald attended the University of Delaware, where he received a Bachelor of Science in Chemical Engineering in 1981. He also completed the Advanced Management Program at Harvard Biness School in 1998.
Jesus B. Mantas

Jesus B. Mantas 是负责IBM业务转型服务部门的全球管理合伙人,他还负责IBM咨询企业发展。Mantas先生是IBM执行绩效团队、IBM执行技术团队和IBM主席加速团队的成员,并且是IBM西班牙裔多元化委员会的名誉主席。他在世界经济论坛的全球人工智能委员会和HITEC的董事会任职,HITEC是一家专注于发展和推进西班牙裔高管在科技行业职业生涯的非营利组织。他是Benhamou Global Ventures Fund IV的有限合伙人,Benhamou Global Ventures Fund IV是一家专注于数字化转型的早期公司的投资基金,并且是西班牙裔主导的早期公司的积极投资者。从2002年到2016年,Mantas先生领导IBM的商业咨询部门,该部门是世界上最大的咨询机构之一。此前,他曾担任IBM全球流程服务和业务服务部门在拉丁美洲的领导职务,此前他曾担任北美副总裁的多个领导职位。在加入IBM之前,Mantas先生是普华永道咨询公司的合伙人、加州大学欧文分校管理研究生院的兼职教授和西班牙空军的一名军官。


Jesus B. Mantas,served as Global Managing Partner of IBM Global Business Services (2022–2025) after a distinguished 20-year career at IBM (2002–2022), where he held leadership roles including Global Managing Partner for Strategy, Innovation and Corporate Development, Global Managing Partner for IBM Business Consulting, and General Manager for IBM Business Process Outsourcing. Earlier, he was a Partner in PricewaterhouseCoopers Consulting's High Technology Practice (1997–2002) and an Adjunct Professor at UC Irvine's Paul Merage School of Business (1997–2001). His career began as a Second Lieutenant in the Spanish Air Force (1993). He holds a B.S. in Telecommunications – Software Engineering and a Degree in Business Administration from Universidad Politécnica de Madrid, complemented by executive education in Corporate Governance from Harvard Business School.
Jesus B. Mantas 是负责IBM业务转型服务部门的全球管理合伙人,他还负责IBM咨询企业发展。Mantas先生是IBM执行绩效团队、IBM执行技术团队和IBM主席加速团队的成员,并且是IBM西班牙裔多元化委员会的名誉主席。他在世界经济论坛的全球人工智能委员会和HITEC的董事会任职,HITEC是一家专注于发展和推进西班牙裔高管在科技行业职业生涯的非营利组织。他是Benhamou Global Ventures Fund IV的有限合伙人,Benhamou Global Ventures Fund IV是一家专注于数字化转型的早期公司的投资基金,并且是西班牙裔主导的早期公司的积极投资者。从2002年到2016年,Mantas先生领导IBM的商业咨询部门,该部门是世界上最大的咨询机构之一。此前,他曾担任IBM全球流程服务和业务服务部门在拉丁美洲的领导职务,此前他曾担任北美副总裁的多个领导职位。在加入IBM之前,Mantas先生是普华永道咨询公司的合伙人、加州大学欧文分校管理研究生院的兼职教授和西班牙空军的一名军官。
Jesus B. Mantas,served as Global Managing Partner of IBM Global Business Services (2022–2025) after a distinguished 20-year career at IBM (2002–2022), where he held leadership roles including Global Managing Partner for Strategy, Innovation and Corporate Development, Global Managing Partner for IBM Business Consulting, and General Manager for IBM Business Process Outsourcing. Earlier, he was a Partner in PricewaterhouseCoopers Consulting's High Technology Practice (1997–2002) and an Adjunct Professor at UC Irvine's Paul Merage School of Business (1997–2001). His career began as a Second Lieutenant in the Spanish Air Force (1993). He holds a B.S. in Telecommunications – Software Engineering and a Degree in Business Administration from Universidad Politécnica de Madrid, complemented by executive education in Corporate Governance from Harvard Business School.
Dawn C. Willoughby

Dawn C. Willoughby于2020年3月加入泰科电子有限公司的董事会。Willoughby女士于2014年9月至2019年1月期间担任高乐氏公司的执行副总裁兼首席运营官,高乐氏公司是一家消费和专业产品的制造商和营销商。她还担任高乐氏公司高级副总裁兼Clorox清洁事业部总经理;家庭护理产品副总裁兼总经理;Glad Products副总裁兼总经理,以及自2001年开始在高乐氏工作以来的其他几个职位。在她在Clorox公司工作之前,Willoughby女士在宝洁公司工作了9年,在那里她担任过几个销售管理职位,Willoughby女士在明尼苏达大学获得了体育管理学士学位,在加利福尼亚大学洛杉矶安德森商学院获得了MBA学位,Willoughby女士是J.M.Smucker公司的董事。


Dawn C. Willoughby served as the Executive Vice President and Chief Operating Officer of The Clorox Company, a manufacturer and marketer of consumer and professional products, from 2014 until 2019. She also served as the company's Senior Vice President and General Manager, Clorox Cleaning Division; Vice President and General Manager, Home Care Products; and Vice President and General Manager, Glad Products, along with several other positions since she was initially hired in 2001. Prior to her career at The Clorox Company, Ms. Willoughby spent nine years with The Procter & Gamble Company, where she held several positions in sales management. She serves as a director of J.M. Smucker Company, a manufacturer and marketer of branded food and beverage products, since 2017, and TE Connectivity, an engineering, design and manufacturer of sensors and electrical connectivity solutions, since March 2020.Ms. Willoughby holds a bachelor's degree in Sports Management from the University of Minnesota and a master's degree in Biness Administration from the University of California, Los Angeles Anderson School of Biness.
Dawn C. Willoughby于2020年3月加入泰科电子有限公司的董事会。Willoughby女士于2014年9月至2019年1月期间担任高乐氏公司的执行副总裁兼首席运营官,高乐氏公司是一家消费和专业产品的制造商和营销商。她还担任高乐氏公司高级副总裁兼Clorox清洁事业部总经理;家庭护理产品副总裁兼总经理;Glad Products副总裁兼总经理,以及自2001年开始在高乐氏工作以来的其他几个职位。在她在Clorox公司工作之前,Willoughby女士在宝洁公司工作了9年,在那里她担任过几个销售管理职位,Willoughby女士在明尼苏达大学获得了体育管理学士学位,在加利福尼亚大学洛杉矶安德森商学院获得了MBA学位,Willoughby女士是J.M.Smucker公司的董事。
Dawn C. Willoughby served as the Executive Vice President and Chief Operating Officer of The Clorox Company, a manufacturer and marketer of consumer and professional products, from 2014 until 2019. She also served as the company's Senior Vice President and General Manager, Clorox Cleaning Division; Vice President and General Manager, Home Care Products; and Vice President and General Manager, Glad Products, along with several other positions since she was initially hired in 2001. Prior to her career at The Clorox Company, Ms. Willoughby spent nine years with The Procter & Gamble Company, where she held several positions in sales management. She serves as a director of J.M. Smucker Company, a manufacturer and marketer of branded food and beverage products, since 2017, and TE Connectivity, an engineering, design and manufacturer of sensors and electrical connectivity solutions, since March 2020.Ms. Willoughby holds a bachelor's degree in Sports Management from the University of Minnesota and a master's degree in Biness Administration from the University of California, Los Angeles Anderson School of Biness.
Cynthia T. Jamison

Cynthia Jamison是一位经验丰富的高管,拥有20多年的企业董事会和财务领导经验。Jamison女士目前担任Darden Restaurants和Big Lots的董事会主席,之前担任Tractor Supply Co.的主席。在专注于董事会服务之前,Jamison女士担任AquaSpy, Inc.的首席财务官,并在不同公司的增长或周转期间担任首席财务官。从1999年到2009年,Jamison女士担任Tatum LLP的管理合伙人,领导CFO服务实践,并监督全国400多名CFO。她还曾担任多家公司的首席财务官或首席运营官,包括eMac, Inc., Cosi, Inc.,SurePayroll和Illinois Superconductor。Jamison女士的早期职业生涯包括在Chart House Enterprises、Allied Domecq Retailing USA、Kraft General Foods和Arthur Andersen LLP担任职务。Jamison是公认的金融和经济问题专家,经常就首席财务官和董事会治理相关主题发表演讲。Jamison女士是NACD D100成员之一的NACD董事会领导研究员。


Cynthia T. Jamison had an Executive career as a turnaround Chief Financial Officer ("CFO"), she has been the CFO or Chief Operating Officer of several publicly and privately held companies including AquaSpy Inc., a soil diagnostic company, eMac, lnc, a joint venture beten McDonald's Corporation and KKR & Co. L.P., Cosi, lnc., the casual dining chain, SurePayroll, a payroll processing firm, and Illinois Superconductor, a radio frequency cellular technology company. She also served as a partner with Tatum, LLP from June 1999 to May 2009. From 2006 on, Ms. Jamison was in a Managing Partner role within Tatum, LLP, and served in several additional capacities, including as Managing Partner of the CFO Services practice. Ms. Jamison had previoly held Executive/Financial leadership roles at Arthur Andersen, Kraft General Foods, Hewitt Associates, Allied Domecq (Dunkin' Donuts/Baskin Robbins) and Chart Hoe Enterprises. She currently serves as Chair of the Board of Darden Restaurants, a hospitality company, and is a Trtee and Chair of the Nominations & Governance committee at Save the Children, a leading charity/non profit organization. Ms. Jamison is a former board Chair of Tractor Supply Company, a retail company, from 2002 to 2023; and a former Board member of ODP Corp from 2013 to 2025 and B&G Foods, an American branded foods company, from 2004 to 2015, as ll as several others.Ms. Jamison earned a B.A. in Political Science and Economics from Duke University and an MBA from the University of Chicago in Finance. Ms. Jamison is also a certified public accountant.
Cynthia Jamison是一位经验丰富的高管,拥有20多年的企业董事会和财务领导经验。Jamison女士目前担任Darden Restaurants和Big Lots的董事会主席,之前担任Tractor Supply Co.的主席。在专注于董事会服务之前,Jamison女士担任AquaSpy, Inc.的首席财务官,并在不同公司的增长或周转期间担任首席财务官。从1999年到2009年,Jamison女士担任Tatum LLP的管理合伙人,领导CFO服务实践,并监督全国400多名CFO。她还曾担任多家公司的首席财务官或首席运营官,包括eMac, Inc., Cosi, Inc.,SurePayroll和Illinois Superconductor。Jamison女士的早期职业生涯包括在Chart House Enterprises、Allied Domecq Retailing USA、Kraft General Foods和Arthur Andersen LLP担任职务。Jamison是公认的金融和经济问题专家,经常就首席财务官和董事会治理相关主题发表演讲。Jamison女士是NACD D100成员之一的NACD董事会领导研究员。
Cynthia T. Jamison had an Executive career as a turnaround Chief Financial Officer ("CFO"), she has been the CFO or Chief Operating Officer of several publicly and privately held companies including AquaSpy Inc., a soil diagnostic company, eMac, lnc, a joint venture beten McDonald's Corporation and KKR & Co. L.P., Cosi, lnc., the casual dining chain, SurePayroll, a payroll processing firm, and Illinois Superconductor, a radio frequency cellular technology company. She also served as a partner with Tatum, LLP from June 1999 to May 2009. From 2006 on, Ms. Jamison was in a Managing Partner role within Tatum, LLP, and served in several additional capacities, including as Managing Partner of the CFO Services practice. Ms. Jamison had previoly held Executive/Financial leadership roles at Arthur Andersen, Kraft General Foods, Hewitt Associates, Allied Domecq (Dunkin' Donuts/Baskin Robbins) and Chart Hoe Enterprises. She currently serves as Chair of the Board of Darden Restaurants, a hospitality company, and is a Trtee and Chair of the Nominations & Governance committee at Save the Children, a leading charity/non profit organization. Ms. Jamison is a former board Chair of Tractor Supply Company, a retail company, from 2002 to 2023; and a former Board member of ODP Corp from 2013 to 2025 and B&G Foods, an American branded foods company, from 2004 to 2015, as ll as several others.Ms. Jamison earned a B.A. in Political Science and Economics from Duke University and an MBA from the University of Chicago in Finance. Ms. Jamison is also a certified public accountant.
Brett Icahn

Brett Icahn是一位受人尊敬的美国投资者和投资组合经理,目前担任Icahn Enterprises L.P.的董事会成员以及Icahn Enterprises旗下Icahn Capital LP的投资组合经理。Icahn Enterprises是一家多元化的控股公司,从事广泛的领域,包括投资、汽车、能源、食品包装、金属、房地产、家居时尚。自2020年10月以来,Icahn先生在管理Icahn Capital的投资策略方面发挥了主导作用。在此之前,2017年至2020年,他担任Icahn Enterprises的顾问,为Carl C. Icahn提供独家投资建议,专注于公司运营子公司和投资组合的资本配置。Icahn获得Princeton大学文学学士学位。


Brett Icahn is an investor and portfolio manager at Icahn Capital, a subsidiary of Icahn Enterprises. Icahn Enterprises is a diversified holding company engaged in a wide range of sectors, including investment, automotive, energy, food packaging, real estate, and home fashion. Since October 2020, Mr. Icahn has played a leading role in managing the investment strategy for Icahn Capital. He is currently serving on the boards of SandRidge Energy, Inc., an independent oil and natural gas company foced on the acquisition, development, and production of oil and gas properties, since 2020, and CVR Energy, a diversified holding company that operates in the petroleum refining and marketing, renewable fuels, and nitrogen fertilizer binesses, since 2025. Mr. Icahn was a director of Icahn Enterprises LP, a diversified holding company that owns a variety of subsidiaries operating in different sectors, from 2020 to 2025; Bach Health Companies Inc., a global diversified pharmaceutical company, from 2021 to 2025; Bach + Lomb Corporation, an eye health company, from 2022 to 2025; and Dana Inc., an automotive supplier company, from 2022 to 2023 and January 2025 to June 2025.Mr. Icahn holds a Bachelor of Arts from Princeton University.
Brett Icahn是一位受人尊敬的美国投资者和投资组合经理,目前担任Icahn Enterprises L.P.的董事会成员以及Icahn Enterprises旗下Icahn Capital LP的投资组合经理。Icahn Enterprises是一家多元化的控股公司,从事广泛的领域,包括投资、汽车、能源、食品包装、金属、房地产、家居时尚。自2020年10月以来,Icahn先生在管理Icahn Capital的投资策略方面发挥了主导作用。在此之前,2017年至2020年,他担任Icahn Enterprises的顾问,为Carl C. Icahn提供独家投资建议,专注于公司运营子公司和投资组合的资本配置。Icahn获得Princeton大学文学学士学位。
Brett Icahn is an investor and portfolio manager at Icahn Capital, a subsidiary of Icahn Enterprises. Icahn Enterprises is a diversified holding company engaged in a wide range of sectors, including investment, automotive, energy, food packaging, real estate, and home fashion. Since October 2020, Mr. Icahn has played a leading role in managing the investment strategy for Icahn Capital. He is currently serving on the boards of SandRidge Energy, Inc., an independent oil and natural gas company foced on the acquisition, development, and production of oil and gas properties, since 2020, and CVR Energy, a diversified holding company that operates in the petroleum refining and marketing, renewable fuels, and nitrogen fertilizer binesses, since 2025. Mr. Icahn was a director of Icahn Enterprises LP, a diversified holding company that owns a variety of subsidiaries operating in different sectors, from 2020 to 2025; Bach Health Companies Inc., a global diversified pharmaceutical company, from 2021 to 2025; Bach + Lomb Corporation, an eye health company, from 2022 to 2025; and Dana Inc., an automotive supplier company, from 2022 to 2023 and January 2025 to June 2025.Mr. Icahn holds a Bachelor of Arts from Princeton University.
Jesus B. Mantas

Jesus Mantas,在IBM咨询公司担任领导10B美元业务转型服务部门的全球管理合伙人。他领导了IBM咨询公司的并购工作,领导了IBM咨询公司的全球战略和产品,并领导了包括IBM全球业务外包、IBM拉丁美洲咨询公司以及IBM咨询公司北美企业市场在内的多个全球部门。在IBM之前,他是普华永道咨询公司技术实践的合伙人。Mantas先生目前在Biogen Inc.董事会担任薪酬和管理发展委员会主席。他担任HITEC的副主席,以及全球竞争与创新委员会的理事会成员,这两个组织都是无党派的非营利组织。他曾担任世界经济论坛AI全球理事会成员,担任加州大学欧文管理研究生院兼职教授,并在西班牙空军担任军官。


Jes B. Mantas is a senior technology and management consulting executive with broad corporate governance experience. He led the $10B Biness Transformation Services unit of IBM Consulting; he also led Strategy, Innovation, M&A and other IBM divisions including IBM Global Biness Outscing, IBM Consulting in Latin America and North America enterprise market during his IBM tenure. Before IBM, he was a Partner in the High Technology practice of PricewaterhoeCoopers Consulting. Prior to his move to the A, he worked for Procter & Gamble and served as an officer in the Air Force of Spain. Mr. Mantas currently serves on the boards of Biogen Inc., a leading biotechnology company; and the National Association of Corporate Directors (NACD). He also serves in the advisory council of NASDAQ Center for Board Excellence and is a trtee of the J. Patrick McGovern Foundation, the world's foremost philanthropy committed to fund public purpose, ethical e of Artificial Intelligence.Mr. Mantas holds degrees in Telecommunications and Biness Administration by Universidad Politécnica de Madrid. He served as an adjunct professor at the University of California Irvine, and has completed Harvard Biness School Corporate Governance.
Jesus Mantas,在IBM咨询公司担任领导10B美元业务转型服务部门的全球管理合伙人。他领导了IBM咨询公司的并购工作,领导了IBM咨询公司的全球战略和产品,并领导了包括IBM全球业务外包、IBM拉丁美洲咨询公司以及IBM咨询公司北美企业市场在内的多个全球部门。在IBM之前,他是普华永道咨询公司技术实践的合伙人。Mantas先生目前在Biogen Inc.董事会担任薪酬和管理发展委员会主席。他担任HITEC的副主席,以及全球竞争与创新委员会的理事会成员,这两个组织都是无党派的非营利组织。他曾担任世界经济论坛AI全球理事会成员,担任加州大学欧文管理研究生院兼职教授,并在西班牙空军担任军官。
Jes B. Mantas is a senior technology and management consulting executive with broad corporate governance experience. He led the $10B Biness Transformation Services unit of IBM Consulting; he also led Strategy, Innovation, M&A and other IBM divisions including IBM Global Biness Outscing, IBM Consulting in Latin America and North America enterprise market during his IBM tenure. Before IBM, he was a Partner in the High Technology practice of PricewaterhoeCoopers Consulting. Prior to his move to the A, he worked for Procter & Gamble and served as an officer in the Air Force of Spain. Mr. Mantas currently serves on the boards of Biogen Inc., a leading biotechnology company; and the National Association of Corporate Directors (NACD). He also serves in the advisory council of NASDAQ Center for Board Excellence and is a trtee of the J. Patrick McGovern Foundation, the world's foremost philanthropy committed to fund public purpose, ethical e of Artificial Intelligence.Mr. Mantas holds degrees in Telecommunications and Biness Administration by Universidad Politécnica de Madrid. He served as an adjunct professor at the University of California Irvine, and has completed Harvard Biness School Corporate Governance.
Richard Mulligan

Richard Mulligan,目前是哈佛医学院的Mallinckrodt遗传学名誉教授,并于2017年3月至2021年2月担任麻省理工学院Koch综合癌症研究所的访问科学家。从2017年3月到2018年10月,他担任投资管理公司Icahn Capital的投资组合经理;从2013年5月到2016年12月,他担任注册投资顾问Sarissa Capital management LP的创始合伙人和高级常务董事。从1996年到2013年,他担任哈佛大学遗传学malinckrodt教授和哈佛基因治疗计划主任。在此之前,他曾担任MIT分子生物学教授和Whitehead Institute for Biomedical Research的成员。Mulligan博士的荣誉包括麦克阿瑟基金会天才奖、美国癌症研究协会罗兹纪念奖、ASMB-Amgen奖和永井基金会国际奖。他持有Stanford大学School of Medicine的生物化学博士学位和MIT的学士学位。Mulligan博士自2018年11月起担任公共生物技术公司Sana Biotechnology, Inc.的董事会成员,自2022年4月起担任副董事长,并自2022年起担任公共制药公司Bausch Health Companies Inc.的董事会成员。2009年6月至2023年6月,他曾担任Biogen Inc.(一家公共生物技术公司)的董事。


Richard Mulligan is currently the Mallinckrodt Professor of Genetics, Emerit, at Harvard Medical School, and served as Visiting Scientist at the Koch Institute for Integrative Cancer Research at the Massachetts Institute of Technology (MIT) from March 2017 to February 2021. From March 2017 to October 2018, Dr. Mulligan served as Portfolio Manager at Icahn Capital, an investment management firm, and from May 2013 to December 2016, he served as Founding Partner and Senior Managing Director of Sarissa Capital Management LP, a registered investment advisor. From 1996 to 2013, Dr. Mulligan served as the Mallinckrodt Professor of Genetics at Harvard and Director of the Harvard Gene Therapy Initiative. Prior to that, he served as Professor of Molecular Biology at MIT and a member of the Whitehead Institute for Biomedical Research. He is currently serving on the boards of Sana Biotechnology, Inc., a public biotechnology company, since 2018, and Bach Health Companies Inc., a public pharmaceutical company, since 2022. He was a director of Biogen Inc., a public biotechnology company, from 2009 to 2023; Enzon Pharmaceuticals, a pharmaceutical company, from 2011 to 2013; and Cellectis SA, is a clinical stage biotechnology company, from 2007 to 2013.Dr. Mulligan offers world class scientific expertise and a track record of innovation that will be valuable to Company as accelerate transformation and deliver stainable, long term value for ctomers, shareholders and employees.
Richard Mulligan,目前是哈佛医学院的Mallinckrodt遗传学名誉教授,并于2017年3月至2021年2月担任麻省理工学院Koch综合癌症研究所的访问科学家。从2017年3月到2018年10月,他担任投资管理公司Icahn Capital的投资组合经理;从2013年5月到2016年12月,他担任注册投资顾问Sarissa Capital management LP的创始合伙人和高级常务董事。从1996年到2013年,他担任哈佛大学遗传学malinckrodt教授和哈佛基因治疗计划主任。在此之前,他曾担任MIT分子生物学教授和Whitehead Institute for Biomedical Research的成员。Mulligan博士的荣誉包括麦克阿瑟基金会天才奖、美国癌症研究协会罗兹纪念奖、ASMB-Amgen奖和永井基金会国际奖。他持有Stanford大学School of Medicine的生物化学博士学位和MIT的学士学位。Mulligan博士自2018年11月起担任公共生物技术公司Sana Biotechnology, Inc.的董事会成员,自2022年4月起担任副董事长,并自2022年起担任公共制药公司Bausch Health Companies Inc.的董事会成员。2009年6月至2023年6月,他曾担任Biogen Inc.(一家公共生物技术公司)的董事。
Richard Mulligan is currently the Mallinckrodt Professor of Genetics, Emerit, at Harvard Medical School, and served as Visiting Scientist at the Koch Institute for Integrative Cancer Research at the Massachetts Institute of Technology (MIT) from March 2017 to February 2021. From March 2017 to October 2018, Dr. Mulligan served as Portfolio Manager at Icahn Capital, an investment management firm, and from May 2013 to December 2016, he served as Founding Partner and Senior Managing Director of Sarissa Capital Management LP, a registered investment advisor. From 1996 to 2013, Dr. Mulligan served as the Mallinckrodt Professor of Genetics at Harvard and Director of the Harvard Gene Therapy Initiative. Prior to that, he served as Professor of Molecular Biology at MIT and a member of the Whitehead Institute for Biomedical Research. He is currently serving on the boards of Sana Biotechnology, Inc., a public biotechnology company, since 2018, and Bach Health Companies Inc., a public pharmaceutical company, since 2022. He was a director of Biogen Inc., a public biotechnology company, from 2009 to 2023; Enzon Pharmaceuticals, a pharmaceutical company, from 2011 to 2013; and Cellectis SA, is a clinical stage biotechnology company, from 2007 to 2013.Dr. Mulligan offers world class scientific expertise and a track record of innovation that will be valuable to Company as accelerate transformation and deliver stainable, long term value for ctomers, shareholders and employees.
Mehmood Khan

Mehmood Khan是进化基金会(Hevolution Foundation)的首席执行官。进化基金会是一家全球性非营利组织,提供赠款和早期公司投资,以激励新兴健康科学领域的独立研究和创业精神。Khan博士是利洁时(Reckitt Benckiser)和沙特研究、发展和创新局的董事会成员,也是沙特国家生物技术战略指导委员会的成员。此前,他曾担任美国国家标准与技术研究所先进技术访问委员会主席,并在2019-2024年担任首席执行官后担任生命生物科学执行主席。在此之前,他曾担任百事公司的副董事长兼全球研发首席科学官。在加入百事公司之前,他曾担任武田全球研发中心总裁,负责监督武田制药公司的全球研发工作。他也是明尼苏达州罗切斯特市梅奥诊所和梅奥医学院的教员。担任内分泌科糖尿病、内分泌和营养试验部门主任。他还在明尼阿波利斯的亨内平县医疗中心(Hennepin County Medical Center)领导了9年的糖尿病、内分泌学、新陈代谢和营养学项目。他是伦敦皇家内科医学院的院士、美国内分泌学院的院士和牛津大学药学系的当选院士。


Mehmood Khan is the CEO of Hevolution Foundation, a first of its kind global non profit organization with a mission to extend healthy lifespan for people everywhere. He was the Executive Chair of Life Biosciences after serving as the CEO from 2019 until 2024. Prior to this role, Dr. Khan served as PepsiCo's Vice Chairman and Chief Scientific Officer of Global Research and Development. Prior to joining PepsiCo, he was President of Takeda Global Research & Development Center, overseeing Takeda Pharmaceuticals Company's worldwide R&D efforts. Dr. Khan was also a faculty member at the Mayo Clinic and Mayo Medical School, serving as Director of the Diabetes, Endocrine and Nutritional Trials Unit in the endocrinology division. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition for the Hennepin County Medical Center. Dr. Khan was a director of Reckitt Benckiser, a multinational company that manufactures and markets products for the home, health and personal care, from 2018 to 2025, and CorMedix Inc., a biopharmaceutical company developing and commercializing therapeutic products for the prevention and treatment of infectio and inflammatory diseases, from 2017 to 2020.Dr. Khan has a medical degree from the University of Liverpool, is a Fellow of the Royal College of Physicians, London and of the American College of Endocrinology, an Elected Fellow in the Department of Pharmacology at University of Oxford and holds two Honorary PhDs in Humanities and International Law.
Mehmood Khan是进化基金会(Hevolution Foundation)的首席执行官。进化基金会是一家全球性非营利组织,提供赠款和早期公司投资,以激励新兴健康科学领域的独立研究和创业精神。Khan博士是利洁时(Reckitt Benckiser)和沙特研究、发展和创新局的董事会成员,也是沙特国家生物技术战略指导委员会的成员。此前,他曾担任美国国家标准与技术研究所先进技术访问委员会主席,并在2019-2024年担任首席执行官后担任生命生物科学执行主席。在此之前,他曾担任百事公司的副董事长兼全球研发首席科学官。在加入百事公司之前,他曾担任武田全球研发中心总裁,负责监督武田制药公司的全球研发工作。他也是明尼苏达州罗切斯特市梅奥诊所和梅奥医学院的教员。担任内分泌科糖尿病、内分泌和营养试验部门主任。他还在明尼阿波利斯的亨内平县医疗中心(Hennepin County Medical Center)领导了9年的糖尿病、内分泌学、新陈代谢和营养学项目。他是伦敦皇家内科医学院的院士、美国内分泌学院的院士和牛津大学药学系的当选院士。
Mehmood Khan is the CEO of Hevolution Foundation, a first of its kind global non profit organization with a mission to extend healthy lifespan for people everywhere. He was the Executive Chair of Life Biosciences after serving as the CEO from 2019 until 2024. Prior to this role, Dr. Khan served as PepsiCo's Vice Chairman and Chief Scientific Officer of Global Research and Development. Prior to joining PepsiCo, he was President of Takeda Global Research & Development Center, overseeing Takeda Pharmaceuticals Company's worldwide R&D efforts. Dr. Khan was also a faculty member at the Mayo Clinic and Mayo Medical School, serving as Director of the Diabetes, Endocrine and Nutritional Trials Unit in the endocrinology division. He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition for the Hennepin County Medical Center. Dr. Khan was a director of Reckitt Benckiser, a multinational company that manufactures and markets products for the home, health and personal care, from 2018 to 2025, and CorMedix Inc., a biopharmaceutical company developing and commercializing therapeutic products for the prevention and treatment of infectio and inflammatory diseases, from 2017 to 2020.Dr. Khan has a medical degree from the University of Liverpool, is a Fellow of the Royal College of Physicians, London and of the American College of Endocrinology, an Elected Fellow in the Department of Pharmacology at University of Oxford and holds two Honorary PhDs in Humanities and International Law.
Paul J. Fribourg

Paul J. Fribourg,自2011年起担任Apollo公司的独立董事、董事会冲突委员会成员。1997年至今,Fribourg先生担任Continental Grain公司董事长兼首席执行官。1997年之前,Fribourg先生曾在大陆谷物公司担任过多种其他职务,包括跟单员、产品线经理、集团总裁和首席运营官。Fribourg先生在餐饮品牌国际公司、美国洛斯保险公司、Castleton Commodities International LLC和雅诗兰黛 Companies,Inc.的董事会任职。他还担任Rabobank International North American Agribusiness Advisory Board、纽约大学Mitchell Jacobson Leadership Program in Law and Business Advisory Board和Endeavor Global Inc.的董事会成员。Fribourg先生还是外交关系委员会和上海市市长国际商业领袖咨询委员会的成员。Fribourg先生以优异成绩毕业于阿默斯特学院,并在哈佛商学院完成了高级管理课程。


Paul J. Fribourg currently serves as Chairman and Chief Executive Officer of Continental Grain Company ("Conti"), a position he has held since 1997. He has overseen Conti's transformation into a diversified global investment firm with a foc on food, agriculture, and adjacent indtries. Under Mr. Fribg's leadership, Conti has expanded its portfolio and strategic partnerships across continents, reinforcing its legacy of innovation and resilience. He currently serves on the boards of Loews Corp., a diversified company, with binesses in the insurance, energy, hospitality and packaging indtries, since 1997, and Estée Lauder Companies Inc., a global leader in prestige beauty, since 2006. Mr. Fribg is also the board chair of Continental Grain Company, an agribiness investment company, since 1976; a board member of Syngenta Group Co. Ltd., a global agricultural technology and innovation company, since 2018; and a board member of Wayne Sanderson Farms LLC, a poultry producer, since 2011.Mr. Fribg earned a Bachelor of Arts degree, magna cum laude, from Amherst College and completed the Advanced Management Program at Harvard Biness School.
Paul J. Fribourg,自2011年起担任Apollo公司的独立董事、董事会冲突委员会成员。1997年至今,Fribourg先生担任Continental Grain公司董事长兼首席执行官。1997年之前,Fribourg先生曾在大陆谷物公司担任过多种其他职务,包括跟单员、产品线经理、集团总裁和首席运营官。Fribourg先生在餐饮品牌国际公司、美国洛斯保险公司、Castleton Commodities International LLC和雅诗兰黛 Companies,Inc.的董事会任职。他还担任Rabobank International North American Agribusiness Advisory Board、纽约大学Mitchell Jacobson Leadership Program in Law and Business Advisory Board和Endeavor Global Inc.的董事会成员。Fribourg先生还是外交关系委员会和上海市市长国际商业领袖咨询委员会的成员。Fribourg先生以优异成绩毕业于阿默斯特学院,并在哈佛商学院完成了高级管理课程。
Paul J. Fribourg currently serves as Chairman and Chief Executive Officer of Continental Grain Company ("Conti"), a position he has held since 1997. He has overseen Conti's transformation into a diversified global investment firm with a foc on food, agriculture, and adjacent indtries. Under Mr. Fribg's leadership, Conti has expanded its portfolio and strategic partnerships across continents, reinforcing its legacy of innovation and resilience. He currently serves on the boards of Loews Corp., a diversified company, with binesses in the insurance, energy, hospitality and packaging indtries, since 1997, and Estée Lauder Companies Inc., a global leader in prestige beauty, since 2006. Mr. Fribg is also the board chair of Continental Grain Company, an agribiness investment company, since 1976; a board member of Syngenta Group Co. Ltd., a global agricultural technology and innovation company, since 2018; and a board member of Wayne Sanderson Farms LLC, a poultry producer, since 2011.Mr. Fribg earned a Bachelor of Arts degree, magna cum laude, from Amherst College and completed the Advanced Management Program at Harvard Biness School.
Virginia C. Drosos

Virginia C. Drosos,她是个体化治疗公司Assurex Health的总裁。2012年9月退休之前,担任Procter & Gamble Company的集团总裁,该公司是世界上品牌销售包装产品主要制造商之一。在Procter & Gamble的25年间, 她担任多职。担任集团总裁期间,她负责价值60亿美元的生意的运营、损益、战略、创新和长期商业发展。她是美国金融集团(American Financial Group)的董事。


Virginia C. Drosos served as the Chief Executive Officer of Signet Jelers Ltd. ("Signet"), the world's largest retailer of diamond jelry, from Augt 2017 to November 2024. During her tenure, she led Signet through a significant transformation, expanding its digital capabilities and enhancing the ctomer experience to deliver total shareholder returns more than five times the retail indtry average. Prior to her role at Signet, Ms. Drosos was Chief Executive Officer of Assurex Health, Inc. ("Assurex"), where she delivered significant revenue growth and executed the strategic sale of the company. Prior to Assurex, she spent 25 years at The Procter & Gamble Company, including as Group President Global Beauty, where she established herself as a transformative leader who led game changing innovation, built multibillion dollar brands, and reinvented global categories. Ms. Drosos served as a director of Foot Locker, Inc. from 2022 to 2025, Signet Jelers Ltd. from 2012 to 2024, and American Financial Group, Inc. from 2013 to 2021.Ms. Drosos holds a Bachelor of Biness Administration from the Terry School, University of Georgia, and a Master of Biness Administration from the Wharton School, University of Pennsylvania.
Virginia C. Drosos,她是个体化治疗公司Assurex Health的总裁。2012年9月退休之前,担任Procter & Gamble Company的集团总裁,该公司是世界上品牌销售包装产品主要制造商之一。在Procter & Gamble的25年间, 她担任多职。担任集团总裁期间,她负责价值60亿美元的生意的运营、损益、战略、创新和长期商业发展。她是美国金融集团(American Financial Group)的董事。
Virginia C. Drosos served as the Chief Executive Officer of Signet Jelers Ltd. ("Signet"), the world's largest retailer of diamond jelry, from Augt 2017 to November 2024. During her tenure, she led Signet through a significant transformation, expanding its digital capabilities and enhancing the ctomer experience to deliver total shareholder returns more than five times the retail indtry average. Prior to her role at Signet, Ms. Drosos was Chief Executive Officer of Assurex Health, Inc. ("Assurex"), where she delivered significant revenue growth and executed the strategic sale of the company. Prior to Assurex, she spent 25 years at The Procter & Gamble Company, including as Group President Global Beauty, where she established herself as a transformative leader who led game changing innovation, built multibillion dollar brands, and reinvented global categories. Ms. Drosos served as a director of Foot Locker, Inc. from 2022 to 2025, Signet Jelers Ltd. from 2012 to 2024, and American Financial Group, Inc. from 2013 to 2021.Ms. Drosos holds a Bachelor of Biness Administration from the Terry School, University of Georgia, and a Master of Biness Administration from the Wharton School, University of Pennsylvania.
Cynthia T. Jamison

Cynthia T. Jamison 是一位退休的转型首席财务官。她最近于2010年至 2013年担任AquaSpy, Inc.的首席财务官。在加入AquaSpy之前,她作为 Tatum, LLC的合伙人,在上市公司和私营公司担任过其他六位首席财务官和/或首席运营官职务,Tatum, LLC专注于为公共和私募股权公司提供临时CFO服务。她还在Tatum领导了四年的首席财务官实践,负责管理300多个首席财务官合伙人,并担任公司运营委员会的成员。在加入 Tatum之前,她于1998年至1999年担任上市餐饮公司Chart House Enterprises的首席财务官,此前曾在Allied Domecq Retailing USA、Kraft General Foods和Arthur Andersen担任多个行政职务。她拥有伊利诺伊州注册会计师的称号;此外,她还是NACD研究员和NACD大师班的常任教员。


Cynthia T. Jamison,is a retired turnaround CFO. She most recently served as CFO of AquaSpy, Inc. from 2010 to 2013. Prior to AquaSpy she held six other CFO and/or COO roles in both public and private companies as a Partner with Tatum, LLC, an executive services firm focusing exclusively on providing interim CFO Services to public and private equity companies. She also led the CFO Practice at Tatum for four years where she had responsibility for over 300 CFO Partners and sat on the firm's Operating Committee. Prior to joining Tatum, she served as CFO of Chart House Enterprises, a publicly traded restaurant company, from 1998 to 1999 and previously held various executive positions at Allied Domecq Retailing USA, Kraft General Foods, and Arthur Andersen. She holds the designation of Certified Public Accountant (Illinois); in addition, she is an NACD Fellow and a frequent faculty member at NACD Master Classes. She recently completed a four-year appointment to the Financial Accounting Standards Advisory Council (FASAC), an Advisory Board to FASB.
Cynthia T. Jamison 是一位退休的转型首席财务官。她最近于2010年至 2013年担任AquaSpy, Inc.的首席财务官。在加入AquaSpy之前,她作为 Tatum, LLC的合伙人,在上市公司和私营公司担任过其他六位首席财务官和/或首席运营官职务,Tatum, LLC专注于为公共和私募股权公司提供临时CFO服务。她还在Tatum领导了四年的首席财务官实践,负责管理300多个首席财务官合伙人,并担任公司运营委员会的成员。在加入 Tatum之前,她于1998年至1999年担任上市餐饮公司Chart House Enterprises的首席财务官,此前曾在Allied Domecq Retailing USA、Kraft General Foods和Arthur Andersen担任多个行政职务。她拥有伊利诺伊州注册会计师的称号;此外,她还是NACD研究员和NACD大师班的常任教员。
Cynthia T. Jamison,is a retired turnaround CFO. She most recently served as CFO of AquaSpy, Inc. from 2010 to 2013. Prior to AquaSpy she held six other CFO and/or COO roles in both public and private companies as a Partner with Tatum, LLC, an executive services firm focusing exclusively on providing interim CFO Services to public and private equity companies. She also led the CFO Practice at Tatum for four years where she had responsibility for over 300 CFO Partners and sat on the firm's Operating Committee. Prior to joining Tatum, she served as CFO of Chart House Enterprises, a publicly traded restaurant company, from 1998 to 1999 and previously held various executive positions at Allied Domecq Retailing USA, Kraft General Foods, and Arthur Andersen. She holds the designation of Certified Public Accountant (Illinois); in addition, she is an NACD Fellow and a frequent faculty member at NACD Master Classes. She recently completed a four-year appointment to the Financial Accounting Standards Advisory Council (FASAC), an Advisory Board to FASB.

高管简历

中英对照 |  中文 |  英文
J. Erik Fyrwald

J. Erik Fyrwald,自2024年2月6日起担任首席执行官、董事会成员。他从先正达加入International Flavors & Fragrances Inc.,自2016年起担任首席执行官。在任职先正达之前,Fyrwald先生于2012年5月至2016年5月期间担任Univar Solutions的首席执行官,于2008年至2011年期间担任纳尔科的董事长兼首席执行官,在纳尔科与艺康集团公司合并后,他担任艺康的总裁。Fyrwald先生的职业生涯始于1981年的杜邦公司。Fyrwald先生在杜邦27年期间担任过多个职位,包括E.I. du Pont de Nemours and Company农业和营养部门的集团副总裁以及杜邦营养和健康业务的副总裁兼总经理。Fyrwald先生就读于特拉华大学,并于1981年获得化学工程理学学士学位。他还于1998年在哈佛商学院完成了高级管理课程。


J. Erik Fyrwald served as Chief Executive Officer and a member of Board of Directors since February 6, 2024. He joined from Syngenta Group, where he served as Chief Executive Officer since 2016. Prior to his role at Syngenta, Mr. Fyrwald served as Chief Executive Officer of Univar Solutions from May 2012 until May 2016, Chairman and Chief Executive Officer of Nalco Company from 2008 until 2011, when Nalco merged with Ecolab Inc. Following the merger, he served as President of Ecolab. Mr. Fyrwald began his career at DuPont in 1981. During his 27 years at DuPont, Mr. Fyrwald held a number of positions, including Group Vice President of the Agriculture and Nutrition Division at E.I. du Pont de Nems and Company and Vice President and General Manager of DuPont's Nutrition and Health Biness. He serves as a director of Eli Lilly and Company, a pharmaceutical company that develops, manufactures, and sells prescription drugs and other healthcare products, since 2005.Mr. Fyrwald attended the University of Delaware, where he received a Bachelor of Science in Chemical Engineering in 1981. He also completed the Advanced Management Program at Harvard Biness School in 1998.
J. Erik Fyrwald,自2024年2月6日起担任首席执行官、董事会成员。他从先正达加入International Flavors & Fragrances Inc.,自2016年起担任首席执行官。在任职先正达之前,Fyrwald先生于2012年5月至2016年5月期间担任Univar Solutions的首席执行官,于2008年至2011年期间担任纳尔科的董事长兼首席执行官,在纳尔科与艺康集团公司合并后,他担任艺康的总裁。Fyrwald先生的职业生涯始于1981年的杜邦公司。Fyrwald先生在杜邦27年期间担任过多个职位,包括E.I. du Pont de Nemours and Company农业和营养部门的集团副总裁以及杜邦营养和健康业务的副总裁兼总经理。Fyrwald先生就读于特拉华大学,并于1981年获得化学工程理学学士学位。他还于1998年在哈佛商学院完成了高级管理课程。
J. Erik Fyrwald served as Chief Executive Officer and a member of Board of Directors since February 6, 2024. He joined from Syngenta Group, where he served as Chief Executive Officer since 2016. Prior to his role at Syngenta, Mr. Fyrwald served as Chief Executive Officer of Univar Solutions from May 2012 until May 2016, Chairman and Chief Executive Officer of Nalco Company from 2008 until 2011, when Nalco merged with Ecolab Inc. Following the merger, he served as President of Ecolab. Mr. Fyrwald began his career at DuPont in 1981. During his 27 years at DuPont, Mr. Fyrwald held a number of positions, including Group Vice President of the Agriculture and Nutrition Division at E.I. du Pont de Nems and Company and Vice President and General Manager of DuPont's Nutrition and Health Biness. He serves as a director of Eli Lilly and Company, a pharmaceutical company that develops, manufactures, and sells prescription drugs and other healthcare products, since 2005.Mr. Fyrwald attended the University of Delaware, where he received a Bachelor of Science in Chemical Engineering in 1981. He also completed the Advanced Management Program at Harvard Biness School in 1998.
Deborah Borg

Deborah Borg,拥有超过20年的人力资本管理经验,包括她最近担任邦吉有限公司(一家农业企业和食品公司)的首席人力资源和通信官。2016年1月接任Bunge Limited首席人力资源官的职位。加入Bunge之前,她在Dow Chemical任职,担任Dow USA总裁,负责区域业务战略以及与客户、政府组织和合资企业合伙人之间的外部关系。她于2000年加入Dow担任澳大利亚/新西兰人力资源经理开始自己的职业生涯,之后继续担任亚洲、欧洲和北美地区业务人力资源职位。她还曾担任全球人力资源主管、营销和销售主管;领导Dow人力资本规划和开发职能部门,专注于人才获取、保留、多样性和发展。之前,Borg曾在General Motors Australia担任人力资源和人才开发职位。她持有澳大利亚Victoria University人力资源管理学士学位;培训和改变管理硕士学位。


Deborah Borg has served as Executive Vice President, Chief People & Culture Officer since Augt 2022. Ms. Borg joined IFF from Bunge Limited, where she served as Chief Human Resces and Communications Officer since 2016. Prior to joining Bunge, she served in a variety of biness leadership and Human Resces roles in Atralia, Switzerland and the U.S. for Dow Chemical beten 2000 and 2015. She began her career at General Motors Atralia.
Deborah Borg,拥有超过20年的人力资本管理经验,包括她最近担任邦吉有限公司(一家农业企业和食品公司)的首席人力资源和通信官。2016年1月接任Bunge Limited首席人力资源官的职位。加入Bunge之前,她在Dow Chemical任职,担任Dow USA总裁,负责区域业务战略以及与客户、政府组织和合资企业合伙人之间的外部关系。她于2000年加入Dow担任澳大利亚/新西兰人力资源经理开始自己的职业生涯,之后继续担任亚洲、欧洲和北美地区业务人力资源职位。她还曾担任全球人力资源主管、营销和销售主管;领导Dow人力资本规划和开发职能部门,专注于人才获取、保留、多样性和发展。之前,Borg曾在General Motors Australia担任人力资源和人才开发职位。她持有澳大利亚Victoria University人力资源管理学士学位;培训和改变管理硕士学位。
Deborah Borg has served as Executive Vice President, Chief People & Culture Officer since Augt 2022. Ms. Borg joined IFF from Bunge Limited, where she served as Chief Human Resces and Communications Officer since 2016. Prior to joining Bunge, she served in a variety of biness leadership and Human Resces roles in Atralia, Switzerland and the U.S. for Dow Chemical beten 2000 and 2015. She began her career at General Motors Atralia.
Leticia Goncalves

Leticia Goncalves,自2020年1月起担任全球特种配料总裁。2018年9月至2020年1月在拜耳担任高级副总裁兼美国部门主管。2014年8月至2018年8月在孟山都担任欧洲和中东地区总裁。


Leticia Goncalves,President, Precision Fermentation and ADM Ventures since November 2023.She is President, Global Foods from March 2021 to November 2023. President, Global Specialty Ingredients from January 2020 to March 2021. Senior Vice President and U.S. Division Head at Bayer from September 2018 to January 2020. President, Europe and Middle East at Monsanto from August 2014 to August 2018.
Leticia Goncalves,自2020年1月起担任全球特种配料总裁。2018年9月至2020年1月在拜耳担任高级副总裁兼美国部门主管。2014年8月至2018年8月在孟山都担任欧洲和中东地区总裁。
Leticia Goncalves,President, Precision Fermentation and ADM Ventures since November 2023.She is President, Global Foods from March 2021 to November 2023. President, Global Specialty Ingredients from January 2020 to March 2021. Senior Vice President and U.S. Division Head at Bayer from September 2018 to January 2020. President, Europe and Middle East at Monsanto from August 2014 to August 2018.
Michael DeVeau

Michael Deveau自2021年2月起担任国际香精香料公司的高级副总裁,首席投资者关系和沟通官,此前曾于2014年9月至2021年2月担任国香精香料公司的副总裁、投资者关系、沟通和办公室主任以及部门首席财务官,2018年至2020年香飘飘、2016年至2018年企业战略负责人。自2009年加入国际香精香料公司担任投资者关系主管以来,Deveau先生在沟通、财务和战略方面发挥了越来越大的作用和责任。加入国际香精香料公司之前,他曾在跨国食品、零食和饮料公司百事公司担任投资者关系、财务和企业发展方面的领导职务。Deveau先生的职业生涯始于花旗投资研究公司的股票研究分析师。


Michael DeVeau has served as Executive Vice President, Chief Financial Officer since January 2025. Mr. DeVeau served as Senior Vice President, Corporate Finance and Investor Relations from December 2022 to December 2024 and had previoly served as Senior Vice President, Chief Investor Relations & Communications Officer from February 2021 to December 2022, Vice President, Investor Relations, Communications, and Chief of Staff from September 2014 to February 2021, as ll as Divisional Chief Financial Officer, Scent from 2018 to 2020 and Head of Corporate Strategy from 2016 to 2018. Since joining the Company in 2009 as Head of Investor Relations, Mr. DeVeau has held vario roles of increasing scope and responsibility in communications, finance and strategy. Prior to joining the Company, he served in leadership positions in investor relations, finance and corporate development at PepsiCo. Mr. DeVeau began his career as an Equity Research Analyst at Citigroup Investment Research.
Michael Deveau自2021年2月起担任国际香精香料公司的高级副总裁,首席投资者关系和沟通官,此前曾于2014年9月至2021年2月担任国香精香料公司的副总裁、投资者关系、沟通和办公室主任以及部门首席财务官,2018年至2020年香飘飘、2016年至2018年企业战略负责人。自2009年加入国际香精香料公司担任投资者关系主管以来,Deveau先生在沟通、财务和战略方面发挥了越来越大的作用和责任。加入国际香精香料公司之前,他曾在跨国食品、零食和饮料公司百事公司担任投资者关系、财务和企业发展方面的领导职务。Deveau先生的职业生涯始于花旗投资研究公司的股票研究分析师。
Michael DeVeau has served as Executive Vice President, Chief Financial Officer since January 2025. Mr. DeVeau served as Senior Vice President, Corporate Finance and Investor Relations from December 2022 to December 2024 and had previoly served as Senior Vice President, Chief Investor Relations & Communications Officer from February 2021 to December 2022, Vice President, Investor Relations, Communications, and Chief of Staff from September 2014 to February 2021, as ll as Divisional Chief Financial Officer, Scent from 2018 to 2020 and Head of Corporate Strategy from 2016 to 2018. Since joining the Company in 2009 as Head of Investor Relations, Mr. DeVeau has held vario roles of increasing scope and responsibility in communications, finance and strategy. Prior to joining the Company, he served in leadership positions in investor relations, finance and corporate development at PepsiCo. Mr. DeVeau began his career as an Equity Research Analyst at Citigroup Investment Research.
Ana Paula Mendonca

Ana Paula Mendonca,自2022年12月起担任International Flavors & Fragrances Inc. 商业卓越高级副总裁。在此之前,她自2022年2月起担任副总裁、全球配料总裁兼北美消费香精区域总经理,在此之前,自2016年1月起担任北美消费香精副总裁兼区域总经理。Mendonca女士30多年前加入IFF,她的丰富经验扩展到了品类管理(香精、家居、面料和美容)、全球营销和产品创新。


Ana Paula Mendonca,has served as President, Scent since April 2024. Previously, Ms. Mendona served as International lavors & Fragrances Inc. Senior Vice President, Commercial Excellence from December 2022 to February 2024. Prior to that, she served as Vice President, President Global Ingredients & Regional General Manager, North America, Consumer Fragrances since February 2022, and, before that, as Vice President, Regional General Manager, North America, Consumer Fragrances since January 2016. Ms. Mendona joined IFF more than 30 years ago, and her broad experience expands across Category Management (Fine Fragrance, Home, Fabric, and Beauty), Global Marketing, and Product Innovation.
Ana Paula Mendonca,自2022年12月起担任International Flavors & Fragrances Inc. 商业卓越高级副总裁。在此之前,她自2022年2月起担任副总裁、全球配料总裁兼北美消费香精区域总经理,在此之前,自2016年1月起担任北美消费香精副总裁兼区域总经理。Mendonca女士30多年前加入IFF,她的丰富经验扩展到了品类管理(香精、家居、面料和美容)、全球营销和产品创新。
Ana Paula Mendonca,has served as President, Scent since April 2024. Previously, Ms. Mendona served as International lavors & Fragrances Inc. Senior Vice President, Commercial Excellence from December 2022 to February 2024. Prior to that, she served as Vice President, President Global Ingredients & Regional General Manager, North America, Consumer Fragrances since February 2022, and, before that, as Vice President, Regional General Manager, North America, Consumer Fragrances since January 2016. Ms. Mendona joined IFF more than 30 years ago, and her broad experience expands across Category Management (Fine Fragrance, Home, Fabric, and Beauty), Global Marketing, and Product Innovation.
Ralf Finzel

Ralf Finzel,自2022年11月1日起担任国际香精香料股份有限公司执行副总裁兼全球运营官。此前,Finzel先生自2020年起担任休斯顿霍尼韦尔国际性能材料和技术事业部综合供应链副总裁。在此之前,他于2017年7月至2020年3月担任霍尼韦尔国际建筑技术业务集团集成供应链副总裁。他于1999年首次加入德国霍尼韦尔公司,担任运营经理,并在欧洲和美国担任各种职务,职责和范围不断扩大。在加入霍尼韦尔之前,他曾在Hoechst AG担任研究和工厂管理职务。


Ralf Finzel has served as Executive Vice President, Global Operations Officer since November 2022. Previoly, Mr. Finzel served as Vice President of Integrated Supply Chain for Honeyll International Performance Materials and Technologies Biness Group in Hoton since 2020. Prior to that, he served as Vice President of Integrated Supply Chain for Honeyll International Building Technologies Biness Group from July 2017 to March 2020. He first joined Honeyll in Germany as an operations manager in 1999, and held vario roles of increasing responsibility and scope in Europe and the U.S. Prior to joining Honeyll, he worked in research and plant management roles for Hoechst AG.
Ralf Finzel,自2022年11月1日起担任国际香精香料股份有限公司执行副总裁兼全球运营官。此前,Finzel先生自2020年起担任休斯顿霍尼韦尔国际性能材料和技术事业部综合供应链副总裁。在此之前,他于2017年7月至2020年3月担任霍尼韦尔国际建筑技术业务集团集成供应链副总裁。他于1999年首次加入德国霍尼韦尔公司,担任运营经理,并在欧洲和美国担任各种职务,职责和范围不断扩大。在加入霍尼韦尔之前,他曾在Hoechst AG担任研究和工厂管理职务。
Ralf Finzel has served as Executive Vice President, Global Operations Officer since November 2022. Previoly, Mr. Finzel served as Vice President of Integrated Supply Chain for Honeyll International Performance Materials and Technologies Biness Group in Hoton since 2020. Prior to that, he served as Vice President of Integrated Supply Chain for Honeyll International Building Technologies Biness Group from July 2017 to March 2020. He first joined Honeyll in Germany as an operations manager in 1999, and held vario roles of increasing responsibility and scope in Europe and the U.S. Prior to joining Honeyll, he worked in research and plant management roles for Hoechst AG.
Yuvraj Arora

Yuvraj Arora,自2023年6月19日起担任国际香料香精公司执行副总裁兼总裁,滋养。Arora先生从家乐氏北美加入IFF,自2021年4月起担任IFF六个美国品类的总裁。他在家乐氏工作了20多年,从2002年在印度开始,在那里他担任过营销和品类管理方面的职务。他后来在2005年移居美国和2012-2015年移居新加坡后,在市场营销、品牌管理和一般管理方面承担了越来越多的责任。


Yuvraj Arora has served as Chief Commercial Officer and President, Taste since January 2025. Prior to this role, Mr. Arora served as Executive Vice President and President, Nish since June 2023. Mr. Arora joined IFF from Kellogg North America, where he served as the President of the company's six U.S. categories since April 2021. He was with Kellogg for more than 20 years, beginning in India in 2002 where he held roles in marketing and category management. He later assumed roles of increasing responsibility in marketing, brand management and general management upon his relocation to the United States in 2005 and in Singapore from 2012 2015.
Yuvraj Arora,自2023年6月19日起担任国际香料香精公司执行副总裁兼总裁,滋养。Arora先生从家乐氏北美加入IFF,自2021年4月起担任IFF六个美国品类的总裁。他在家乐氏工作了20多年,从2002年在印度开始,在那里他担任过营销和品类管理方面的职务。他后来在2005年移居美国和2012-2015年移居新加坡后,在市场营销、品牌管理和一般管理方面承担了越来越多的责任。
Yuvraj Arora has served as Chief Commercial Officer and President, Taste since January 2025. Prior to this role, Mr. Arora served as Executive Vice President and President, Nish since June 2023. Mr. Arora joined IFF from Kellogg North America, where he served as the President of the company's six U.S. categories since April 2021. He was with Kellogg for more than 20 years, beginning in India in 2002 where he held roles in marketing and category management. He later assumed roles of increasing responsibility in marketing, brand management and general management upon his relocation to the United States in 2005 and in Singapore from 2012 2015.
Stephen Landsman

Stephen Landsman,自2024年8月起担任业务发展执行副总裁。此前,Landsman先生曾于2018年5月至2024年7月担任集团总法律顾问,并于2017年6月至2018年5月在先正达担任全球并购主管。在加入先正达之前,Landsman先生曾于2013年至2017年担任Univar,Inc.的执行副总裁、总法律顾问和公司秘书。在此之前,Landsman先生曾于2003年至2013年在纳尔科公司担任副总裁、总法律顾问和公司秘书,自1990年以来一直在Nalco担任多个领导职务。


Stephen Landsman has served as Executive Vice President, General Counsel since July 2025. From Augt 2024 to July 2025, Mr. Landsman served as Executive Vice President, Biness Development. Previoly, Mr. Landsman served as Group General Counsel from May 2018 to July 2024 and Global Head of Mergers and Acquisitions from June 2017 to May 2018 with Syngenta. Prior to joining Syngenta, Mr. Landsman served as Executive Vice President, General Counsel and Corporate Secretary for Univar, Inc. from 2013 to 2017. Prior to that, Mr. Landsman served as Vice President, General Counsel and Corporate Secretary at Nalco Company from 2003 to 2013, following vario leadership positions within Nalco since 1990.
Stephen Landsman,自2024年8月起担任业务发展执行副总裁。此前,Landsman先生曾于2018年5月至2024年7月担任集团总法律顾问,并于2017年6月至2018年5月在先正达担任全球并购主管。在加入先正达之前,Landsman先生曾于2013年至2017年担任Univar,Inc.的执行副总裁、总法律顾问和公司秘书。在此之前,Landsman先生曾于2003年至2013年在纳尔科公司担任副总裁、总法律顾问和公司秘书,自1990年以来一直在Nalco担任多个领导职务。
Stephen Landsman has served as Executive Vice President, General Counsel since July 2025. From Augt 2024 to July 2025, Mr. Landsman served as Executive Vice President, Biness Development. Previoly, Mr. Landsman served as Group General Counsel from May 2018 to July 2024 and Global Head of Mergers and Acquisitions from June 2017 to May 2018 with Syngenta. Prior to joining Syngenta, Mr. Landsman served as Executive Vice President, General Counsel and Corporate Secretary for Univar, Inc. from 2013 to 2017. Prior to that, Mr. Landsman served as Vice President, General Counsel and Corporate Secretary at Nalco Company from 2003 to 2013, following vario leadership positions within Nalco since 1990.
Andres Muller

Andres Muller,2024年12月加入IFF,自2025年1月起担任总裁,食品配料。Muller先生从Corbion加入IFF,自2020年3月起担任可持续食品解决方案总裁,自2015年1月起担任执行委员会成员。此前,Muller先生曾于2013年至2015年在杜邦公司担任全球销售、创新和营销高级副总裁,并于2001年至2013年在Sensient和杜邦营养与健康公司(前身为Danisco)担任营销和销售方面的各种领导职务。穆勒先生于1984年在Sabores y Fragancias开始了他的职业生涯,当时他是一名香水配料师。在无数研发和销售角色后,他组建了flavors and fragrances公司,Bush Boake Allen后来在2000年收购了这家公司。


Andres Muller joined IFF in December 2024 and has served as President, Food Ingredients since January 2025. Mr. Muller joined IFF from Corbion where he served as President, Stainable Food Solutions since March 2020 and was a member of the Executive Committee since January 2015. Previoly, Mr. Muller served as SVP Global Sales, Innovation and Marketing at DuPont from 2013 to 2015 and held vario leadership roles in marketing and sales within Sensient and DuPont Nutrition and Health, formerly Danisco from 2001 to 2013. Mr. Muller began his career at Sabores y Fragancias in 1984 as a fragrance compounder. After numero R&D and sales roles, he formed his own flavors and fragrances company, which Bh Boake Allen later acquired in 2000.
Andres Muller,2024年12月加入IFF,自2025年1月起担任总裁,食品配料。Muller先生从Corbion加入IFF,自2020年3月起担任可持续食品解决方案总裁,自2015年1月起担任执行委员会成员。此前,Muller先生曾于2013年至2015年在杜邦公司担任全球销售、创新和营销高级副总裁,并于2001年至2013年在Sensient和杜邦营养与健康公司(前身为Danisco)担任营销和销售方面的各种领导职务。穆勒先生于1984年在Sabores y Fragancias开始了他的职业生涯,当时他是一名香水配料师。在无数研发和销售角色后,他组建了flavors and fragrances公司,Bush Boake Allen后来在2000年收购了这家公司。
Andres Muller joined IFF in December 2024 and has served as President, Food Ingredients since January 2025. Mr. Muller joined IFF from Corbion where he served as President, Stainable Food Solutions since March 2020 and was a member of the Executive Committee since January 2015. Previoly, Mr. Muller served as SVP Global Sales, Innovation and Marketing at DuPont from 2013 to 2015 and held vario leadership roles in marketing and sales within Sensient and DuPont Nutrition and Health, formerly Danisco from 2001 to 2013. Mr. Muller began his career at Sabores y Fragancias in 1984 as a fragrance compounder. After numero R&D and sales roles, he formed his own flavors and fragrances company, which Bh Boake Allen later acquired in 2000.
Marc Birenkrant

Marc Birenkrant,在财务和会计领域拥有超过30年的经验,自2008年以来一直受雇于IFF。Birenkrant先生曾在公司担任多个领导职务,包括副总裁、助理财务总监、财务总监。Birenkrant先生于1996年至2008年担任温迪公司的会计总监,负责管理会计运营和财务报告。Birenkrant先生的职业生涯始于1994年至1996年在安永会计师事务所担任审计员。Birenkrant先生拥有宾夕法尼亚州立大学会计学理学学士学位,是纽约州的注册会计师。


Marc Birenkrant,has over 30 years of experience in finance and accounting and has been employed by IFF since 2008. Mr. Birenkrant has served in various leadership positions at the Company, including Vice President, Assistant Controller, and Finance Director. Prior to joining the Company, Mr. Birenkrant was Director of Accounting at The Wendy's Company from 1996 to 2008, where he managed accounting operations and financial reporting. Mr. Birenkrant began his career as an auditor at Ernst & Young LLP from 1994 to 1996. Mr. Birenkrant holds a Bachelor of Science degree in Accounting from Pennsylvania State University and is a Certified Public Accountant in the State of New York.
Marc Birenkrant,在财务和会计领域拥有超过30年的经验,自2008年以来一直受雇于IFF。Birenkrant先生曾在公司担任多个领导职务,包括副总裁、助理财务总监、财务总监。Birenkrant先生于1996年至2008年担任温迪公司的会计总监,负责管理会计运营和财务报告。Birenkrant先生的职业生涯始于1994年至1996年在安永会计师事务所担任审计员。Birenkrant先生拥有宾夕法尼亚州立大学会计学理学学士学位,是纽约州的注册会计师。
Marc Birenkrant,has over 30 years of experience in finance and accounting and has been employed by IFF since 2008. Mr. Birenkrant has served in various leadership positions at the Company, including Vice President, Assistant Controller, and Finance Director. Prior to joining the Company, Mr. Birenkrant was Director of Accounting at The Wendy's Company from 1996 to 2008, where he managed accounting operations and financial reporting. Mr. Birenkrant began his career as an auditor at Ernst & Young LLP from 1994 to 1996. Mr. Birenkrant holds a Bachelor of Science degree in Accounting from Pennsylvania State University and is a Certified Public Accountant in the State of New York.
Vivek Verma

Vivek Verma自2021年2月起担任执行副总裁、首席信息官,并曾于2016年至2021年2月担任高级副总裁、首席信息官。在加入公司之前,Verma先生曾在跨国金融服务公司美国运通担任全球基础设施运营副总裁。在此之前,Verma先生还曾在美国运通担任其他几个领导职务,担任副总裁、部门首席信息官以及葛兰素史克、百时美施贵宝和普华永道的管理咨询职务。


Vivek Verma has served as Executive Vice President, Chief Information Officer since February 2021 and had previoly served as Senior Vice President, Chief Information Officer from 2016 to February 2021. Before joining the Company, Mr. Verma served as Vice President of Global Infrastructure Operations at American Express, a multinational financial services company. Prior to that, Mr. Verma held several other leadership positions at American Express as ll as Vice President, Division CIO and management consulting roles with GlaxoSmithKline, Bristol Myers Squibb and PricewaterhoeCoopers.
Vivek Verma自2021年2月起担任执行副总裁、首席信息官,并曾于2016年至2021年2月担任高级副总裁、首席信息官。在加入公司之前,Verma先生曾在跨国金融服务公司美国运通担任全球基础设施运营副总裁。在此之前,Verma先生还曾在美国运通担任其他几个领导职务,担任副总裁、部门首席信息官以及葛兰素史克、百时美施贵宝和普华永道的管理咨询职务。
Vivek Verma has served as Executive Vice President, Chief Information Officer since February 2021 and had previoly served as Senior Vice President, Chief Information Officer from 2016 to February 2021. Before joining the Company, Mr. Verma served as Vice President of Global Infrastructure Operations at American Express, a multinational financial services company. Prior to that, Mr. Verma held several other leadership positions at American Express as ll as Vice President, Division CIO and management consulting roles with GlaxoSmithKline, Bristol Myers Squibb and PricewaterhoeCoopers.